Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherRevenue (Gross)Shares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Design Therapeutics (DSGN) Accumulated Depreciation & Amortization (2020 - 2026)

Design Therapeutics' Accumulated Depreciation & Amortization history spans 2 years, with the latest figure at $134000.0 for Q4 2021.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 2580.0% to $134000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $134000.0, a 2580.0% increase, with the full-year FY2021 number at $134000.0, up 2580.0% from a year prior.
  • Accumulated Depreciation & Amortization hit $134000.0 in Q4 2021 for Design Therapeutics, up from $52000.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for DSGN hit a ceiling of $134000.0 in Q4 2021 and a floor of $5000.0 in Q4 2020.